Statement Concerning the National Lung Screening Trial

First Page		Document Content
Date: 2013-07-09 03:36:18 Cancer Occupational safety and health Pathology Screening Lung cancer Data monitoring committees Medicine Health Medical terms		Statement Concerning the National Lung Screening Trial Add to Reading List Source URL: www.cancer.gov Download Document from Source Website File Size: 519,38 KB Share Document on Facebook

	Journal of Infection and Public Health, S31—S34 EGFR mutation testing in non-small cell lung cancer (NSCLC) Fouad Al Dayel 1 Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital an DocID: 1vjEy - View Document
	RESEARCH Efficacy, safety and economy of icotinib for advanced non-small cell lung cancer: a meta-analysis DocID: 1vfqs - View Document
	Warning: Smoking cigarettes contributes to lung disease, cancer, heart disease, stroke and respiratory illness and during pregnancy may result in low birth weight and premature birth. DocID: 1v3MR - View Document
	Signs and Symptoms of Lung Cancer Mohammed Zeitouni, MD, FCCP Consultant, Pulmonologist and Intensivist Department of Medicine King Faisal Specialist Hospital DocID: 1v06s - View Document
	Lung Cancer Academy Annual ConferenceOctober 2014, Al Faisal University CLASSIFICATION & MOLECULAR MARKERS OF LUNG ADENOCARCINOMA Fouad Al Dayel, MD, FRCPA, FRCPath DocID: 1uZ8r - View Document